The heterogeneity of NOTCH1 to tumor immune infiltration in pan-cancer

被引:1
|
作者
Duan, Xiaojun [1 ,2 ]
Wu, Rihan [3 ]
Zhang, Mingyang [1 ]
Li, Kexin [1 ]
Yu, Lei [1 ]
Sun, Huirong [1 ]
Hao, Xingxia [2 ]
Wang, Changshan [1 ]
机构
[1] Inner Mongolia Univ, Sch Life Sci, Hohhot, Inner Mongolia, Peoples R China
[2] Inner Mongolia Med Univ, Sch Basic Sci, Hohhot, Inner Mongolia, Peoples R China
[3] Inner Mongolia Med Univ, Affiliated Hosp, Dept Oncol, Hohhot, Inner Mongolia, Peoples R China
来源
SCIENTIFIC REPORTS | 2024年 / 14卷 / 01期
关键词
NOTCH1; Tumor heterogeneity; Immune infiltration; Angiogenesis; tsRNA; CELL INFILTRATION; ANGIOGENESIS; NUMB; IMMUNOTHERAPY; MECHANISMS; SUPPRESSOR; CROSSTALK; ANTIBODY; RECEPTOR;
D O I
10.1038/s41598-024-79883-1
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
NOTCH1 signaling, a vital regulator of cell proliferation and differentiation, is widely involved in the occurrence and development of malignant tumors. Pharmacological regulation of NOTCH1 is promising in tumor immunotherapy, whereas the effective rate of existing therapies remains low. NOTCH1 functions, as a cancer suppressor or a cancer promoter in different cancers, is engaged in the crosstalk between the immune microenvironment and cancer cells, posing a major challenge to immunotherapy. Therefore, a comprehensive view of the overall situation of NOTCH1-associated immune infiltration in pan-cancer should be built. The relation between NOTCH1 and immune infiltration was initially investigated in this paper. In this study, the data originated from the Genotype-Tissue Expression (GTEx) and the Cancer Genome Atlas (TCGA) databases were input into multiple online bioinformatic tools to study the characteristics of NOTCH1 in pan-cancer. We found that there was obvious heterogeneity in the NOTCH1-associated tumor immune infiltration in pan-cancer. In accordance with the heterogeneity, pan-cancer mainly fell into two categories, i.e., cancers that NOTCH1 promoted immune infiltration (termed hot tumors) and NOTCH1 inhibited immune infiltration (termed cold tumors). We further analyzed the changes of immune infiltration in pan-carcinoma species from the perspectives of NOTCH1 expression, mutation, gene function, tumor metastasis and drugs. NOTCH1 expression was significantly up-regulated in cold tumors but down-regulated in hot tumors. The Gene ontology (GO) enrichment analysis of NOTCH1 with the two categories placed stress on angiogenesis and protein dealkylation, respectively. Further, the gene sets of angiogenesis facilitated immune infiltration, whereas the gene sets of protein dealkylation hindered immune infiltration. The tsRNA associated with NOTCH1 is a type of angiogenin that potentially exerts a significant influence on angiogenesis. We have conducted a meticulous analysis of the function of this tsRNA. NOTCH1 was conducive to cancer-associated fibroblasts (CAFs) immune infiltration, while the metastatic process was more dependent on the differentiation and angiogenesis function of NOTCH1. Accordingly, the heterogeneity of NOTCH1 in immune infiltration was extensively analyzed in this study based on the pan-cancer study, which can contribute to the formulation of specific immunotherapy strategies.
引用
收藏
页数:18
相关论文
共 50 条
  • [1] The heterogeneity of NOTCH1 to tumor immune infiltration in pan-cancer (vol 14, 28071, 2024)
    Duan, Xiaojun
    Wu, Rihan
    Zhang, Mingyang
    Li, Kexin
    Yu, Lei
    Sun, Huirong
    Hao, Xingxia
    Wang, Changshan
    SCIENTIFIC REPORTS, 2025, 15 (01):
  • [2] The role of CRYAB in tumor prognosis and immune infiltration: A Pan-cancer analysis
    Cheng, Lang
    Zou, Xiong
    Wang, Jiawei
    Zhang, Jiange
    Mo, Zengnan
    Huang, Houbao
    FRONTIERS IN SURGERY, 2023, 9
  • [3] Comprehensive analysis of PILRΑ’s association with the prognosis, tumor immune infiltration, and immunotherapy in pan-cancer
    Qiao Li
    Zhirong Yang
    Xiaoyan He
    Xin Yang
    Scientific Reports, 13
  • [4] Comprehensive analysis of PILR?'s association with the prognosis, tumor immune infiltration, and immunotherapy in pan-cancer
    Li, Qiao
    Yang, Zhirong
    He, Xiaoyan
    Yang, Xin
    SCIENTIFIC REPORTS, 2023, 13 (01)
  • [5] Evaluation of Pan-Cancer Immune Heterogeneity Based on DNA Methylation
    Zhou, Yang
    Liu, Jiebiao
    Shi, Bowen
    Ma, Te
    Yu, Peishen
    Li, Ji
    Gu, Yue
    Zhang, Yan
    GENES, 2025, 16 (02)
  • [6] Evidence of Omics, Immune Infiltration, and Pharmacogenomic for SENP1 in the Pan-Cancer Cohort
    Taghvaei, Somayye
    Sabouni, Farzaneh
    Minuchehr, Zarrin
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [7] Pan-cancer characterization of tumor immune microenvironment.
    Chu, Tianqing
    Bei, Zhang
    CANCER RESEARCH, 2021, 81 (13)
  • [8] Comparing of pan-cancer tumor immune microenvironment.
    Ye, Jiaan
    Cui, Longgang
    Zhao, Xiaochen
    Lan, Guanghui
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [9] Evidence of Omics, Immune Infiltration, and Pharmacogenomics for BATF in a Pan-Cancer Cohort
    Jia, Chenguang
    Ma, Yihui
    Wang, Mengyang
    Liu, Wen
    Tang, Feng
    Chen, Jincao
    FRONTIERS IN MOLECULAR BIOSCIENCES, 2022, 9
  • [10] Comprehensive Landscape of RRM2 with Immune Infiltration in Pan-Cancer
    Zhou, Zijian
    Song, Qiang
    Yang, Yuanyuan
    Wang, Lujia
    Wu, Zhong
    CANCERS, 2022, 14 (12)